Sign In
Buy BLFS
$27.25
-0.240 (-0.87%)
At Close: Jun 03, 2026
BioLife Solutions Promotes Marcus Schulz to Vice President, Global Sales
08:15pm, Monday, 18'th May 2020
BioLife Solutions, Inc. (NASDAQ: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of a portfolio of best-in-class bioproduction tools for cell and gene therapies, today announced t
BioLife Solutions, Inc. (BLFS) CEO Mike Rice on Q1 2020 Results - Earnings Call Transcript
01:46am, Friday, 15'th May 2020
BioLife Solutions, Inc. (NASDAQ:BLFS) Q1 2020 Earnings Conference Call May 14, 2020 4:30 PM ET Company Participants Roderick de Greef - Chief Financial Officer
Biolife Solutions Inc (BLFS) Q1 2020 Earnings Call Transcript
12:30am, Friday, 15'th May 2020
Now I'd like to turn the call over to Mike Rice, President and CEO of BioLife. For the last month or so of the quarter, we had our team members either working from home, part of an essential reduced
BioLife Solutions Announces First Quarter 2020 Financial Results
08:05pm, Thursday, 14'th May 2020
BioLife Solutions, Inc. (NASDAQ: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of a portfolio of class-defining bioproduction tools for cell and gene therapies, today announced
Global Organ Transplant Market Review 2015-2019 and Forecast to 2025 (Impact of COVID-19) - ResearchAndMarkets.com
12:00am, Thursday, 14'th May 2020
The
CytoDyn (CYDY) to Report Q4 Earnings: What's in the Cards?
04:52pm, Wednesday, 13'th May 2020
On CytoDyn's (CYDY) upcoming earnings call, investor focus will be on the updates related to its CCR5 antagonist candidate, leronlimab, which is being developed for multiple therapeutic indications.
Why Earnings Season Could Be Great for BioLife Solutions (BLFS)
02:20pm, Wednesday, 13'th May 2020
BioLife Solutions (BLFS) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
The Daily Biotech Pulse: Gilead Signs Manufacturing Deal For Remdesivir, Bristol-Myers Gets Refuse-To-File Letter
12:00am, Wednesday, 13'th May 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs May 12)
Acceleron Pharma Inc (NASDAQ...
What's in the Cards for SmileDirectClub's (SDC) Q1 Earnings?
12:00am, Tuesday, 12'th May 2020
Stocks Analysis by Zacks Investment Research covering: CVS Health Corp, BioLife Solutions Inc, Hexo Corp, SmileDirectClub Inc. Read Zacks Investment Research's latest article on Investing.com
BioLife Solutions to Report First Quarter 2020 Financial Results and Provide Business Update on May 14th, 2020
12:00pm, Monday, 11'th May 2020
BioLife Solutions, Inc. (NASDAQ: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of a portfolio of best-in-class bioproduction tools for cell and gene therapies, today announced t
The Week Ahead In Biotech: Virtual Conference Presentations, Clovis PDUFA Date In The Spotlight
12:00am, Sunday, 10'th May 2020
The smid-cap biotech earnings deluge hit Wall Street in the week ended May 9, positively impacting the stocks in the sector. The iShares NASDAQ Biotechnology Index (NASDAQ: IBB)...
Analysts' Top Healthcare Picks: Lemaitre Vascular (LMAT), Aerie Pharma (AERI)
12:51pm, Friday, 01'st May 2020
There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Lemaitre Vascular (LMAT), Aerie Pharma (AERI) and BioLife
Analysts’ Top Healthcare Picks: Lemaitre Vascular (LMAT), Aerie Pharma (AERI)
12:51pm, Friday, 01'st May 2020
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Lemaitre Vascular (
LMAT
–
Research Report
), Aerie Pharma (
AERI
–
Research Report
) and BioLife S
BioLife Solutions Announces Preliminary First Quarter 2020 Revenue
12:00pm, Friday, 01'st May 2020
BioLife Solutions, Inc. (NASDAQ: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of a portfolio of best-in-class bioproduction tools for cell and gene therapies, today announced p
